• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Theses
    • Theses - Higher Degree by Research
    • View Item
    • Home
    • Griffith Theses
    • Theses - Higher Degree by Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Role of VPS35 in the pathogenesis of Parkinson's disease

    Thumbnail
    View/Open
    Mohan, Megha_Final Thesis_Redacted.pdf (9.808Mb)
    Author(s)
    Mohan, Megha
    Primary Supervisor
    Mellick, George
    Other Supervisors
    Wood, Stephen
    Year published
    2017-04
    Metadata
    Show full item record
    Abstract
    Parkinson’s disease (PD) is a heterogeneous and complex neurodegenerative disorder whose aetiology is not fully understood. Studying familial Parkinson’s disease has identified several mutations that cause the disease and investigating the functions of these genes has given us clues to the cellular mechanisms that underlie the neurodegenerative phenotype in the patients. A clear understanding of these cellular mechanisms is necessary to halt disease progression. Next generation sequencing of a Swiss kindred with autosomal dominant Parkinson’s disease has identified a causative D620N mutation in the VPS35 (vacuolar sorting ...
    View more >
    Parkinson’s disease (PD) is a heterogeneous and complex neurodegenerative disorder whose aetiology is not fully understood. Studying familial Parkinson’s disease has identified several mutations that cause the disease and investigating the functions of these genes has given us clues to the cellular mechanisms that underlie the neurodegenerative phenotype in the patients. A clear understanding of these cellular mechanisms is necessary to halt disease progression. Next generation sequencing of a Swiss kindred with autosomal dominant Parkinson’s disease has identified a causative D620N mutation in the VPS35 (vacuolar sorting protein 35) gene. The VPS35 protein is a subunit of a retromer complex, which is a key element of the endosomal sorting process. Little is known about the effects of this mutation and this thesis presents our efforts to gain a better understanding of the mechanism by which mutations in the VPS35 gene influences the pathogenesis of PD. This project also investigates disease specific differences in organelles along the retromer pathway in sporadic PD cases. The first cell model used in the study is a fibroblast model derived from a PD patient carrying the D620N mutation and healthy “wild-type” controls. It was found that the D620N mutation did not present any loss of endogenous VPS35 protein levels in the fibroblasts. However, in the presence of the mutation a redistribution of the endosomes was observed. This was indicative of altered endolysosomal trafficking within the cell. Further, defective trafficking of CIMPR, a well-known cargo molecule of the retromer complex was observed in the presence of the mutation. This trafficking defect resulted in compromised lysosomal function mainly through the impaired processing of its ligand cathepsin D, a lysosomal enzyme involved in the degradation of alpha synuclein. In addition to this, high content image analysis of the cells revealed a disease specific difference in features of organelles involved in the retromer trafficking pathway. The fibroblasts were also treated with rotenone to analyse the effects of mitochondrial stress in the presence of the mutation. Treatment with this pesticide which is also a known complex 1 inhibitor, that causes PD like pathology in animals, showed disease specific changes in cells with the mutation. The D620N mutation did not confer increased susceptibility to cell death, but caused disease specific changes in properties of the early endosome, lysosomal and retromer subunit of the fibroblasts. On treatment with rotenone, cathepsin D processing defects were also exacerbated in the patient cells with the mutation. Further, the effect of the D620N mutation on alpha synuclein processing was also investigated. Uptake of monomeric and fibrillar alpha synuclein forms was shown in the fibroblasts. Reduced clearance of the alpha synuclein fibrils was observed in the presence of the D620N mutation. In addition to this, the D620N mutation conferred an increased sensitivity to alpha synuclein toxicity within these cells. Although increased alpha synuclein aggregation in the presence of the D620N mutation was hypothesised, the mutation did not show increased aggregation under the experimental conditions described here. In order to investigate disease specific differences in sporadic patients, a second cell model was used in this study, namely the human olfactory neurosphere derived (hONS) model. Investigation surrounding the retromer functions in hONS cells derived from sporadic PD did not reveal any alterations in the retromer levels and cathepsin D processing defects relative to cells derived from healthy donors. However, a nonsignificant trend towards decreased cathepsin D levels was observed in the patient cells. Analysis of retromer related markers in these cells did not show any disease specific differences. In contrast to this, inducing mitochondrial stress using rotenone resulted in disease specific changes in several organelles within these cells. Treatment with rotenone brought about changes in cellular parameters of mitochondria, lysosomes and tubulin, indicating disease specific responses to mitochondrial stress that served as potential biomarkers for the disease. In conclusion, this study identified retromer trafficking defects and alpha synuclein processing defects in the presence of the D620N mutation. It is the first report that shows synuclein processing defects in fibroblasts from PD patients with the D620N mutation. This study also marks the identification of potential biomarkers for the disease by building on previously identified disease specific differences identified in hONS cells obtained from sporadic PD patients.
    View less >
    Thesis Type
    Thesis (PhD Doctorate)
    Degree Program
    Doctor of Philosophy (PhD)
    School
    School of Natural Sciences
    DOI
    https://doi.org/10.25904/1912/1413
    Copyright Statement
    The author owns the copyright in this thesis, unless stated otherwise.
    Subject
    Parkinson's disease
    Pathogenes
    VPS35 vacuolar sorting protein
    Cellular dysfunctions
    Retromer complex
    Alpha synuclein
    Publication URI
    http://hdl.handle.net/10072/370642
    Collection
    • Theses - Higher Degree by Research

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander